Seeking (and Finding) Biased Ligands of the Kappa Opioid Receptor
- 5 July 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 8 (7) , 694-700
Abstract
The discovery and characterization of two classes of kappa opioid receptor agonists that are biased for G protein over βarrestin signaling are described.Keywords
Funding Information
- National Human Genome Research Institute (5U54HG005031, 5U54HG005033)
- National Institute on Drug Abuse (1X01DA026208, 5R01DA031927, 5U01DA022950)
- National Institute of Mental Health (HHSN-271-2008-00025-C)
- National Institute of General Medical Sciences (5P50GM069663)
This publication has 47 references indexed in Scilit:
- A Simple Method for Quantifying Functional Selectivity and Agonist BiasACS Chemical Neuroscience, 2012
- Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement StrategyACS Chemical Neuroscience, 2012
- Resolution of Carboxylic Acids Using Copper(I)-Promoted Removal of Propargylic Esters under Neutral ConditionsThe Journal of Organic Chemistry, 2011
- N-Alkyl-octahydroisoquinolin-1-one-8-carboxamides: Selective and Nonbasic κ-Opioid Receptor LigandsACS Medicinal Chemistry Letters, 2010
- Kappa opioids promote the proliferation of astrocytes via Gβγ and β‐arrestin 2‐dependent MAPK‐mediated pathwaysJournal of Neurochemistry, 2008
- Stress-Induced p38 Mitogen-Activated Protein Kinase Activation Mediates κ-Opioid-Dependent DysphoriaJournal of Neuroscience, 2007
- Long-Acting κ Opioid Antagonists Disrupt Receptor Signaling And Produce Noncompetitive Effects By Activating C-Jun N-Terminal KinaseJournal of Biological Chemistry, 2007
- How many drug targets are there?Nature Reviews Drug Discovery, 2006
- Kappa Opioid Receptor Activation of p38 MAPK Is GRK3- and Arrestin-dependent in Neurons and AstrocytesJournal of Biological Chemistry, 2006
- Transduction of Receptor Signals by ß-ArrestinsScience, 2005